These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3406047)

  • 1. Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension.
    Borghi L; Elia G; Trapassi MR; Melloni E; Amato F; Barbarese F; Novarini A
    Pharmacology; 1988; 36(5):348-55. PubMed ID: 3406047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of indapamide on the renin-aldosterone system, and urinary excretion of potassium and calcium in essential hypertension.
    Danielsen H; Pedersen EB; Spencer ES
    Br J Clin Pharmacol; 1984 Aug; 18(2):229-31. PubMed ID: 6386023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive and diuretic effects of indapamide in normotensive and hypertensive rats (author's transl)].
    Morishita S; Nishimura K; Kato E; Shirahase H; Osumi S; Kitao K; Seki T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):137-46. PubMed ID: 7084816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of indapamide with thiazide diuretics in patients with essential hypertension.
    Chalmers JP; Bune AJ; Graham JR; West MJ; Wing LM
    Med J Aust; 1981 Jul; 2(2):100-1. PubMed ID: 7300705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive cardiovascular assessment of indapamide in patients with essential hypertension.
    Dunn FG; Hillis WS; Tweddel A; Rae AP; Lorimer AR
    Postgrad Med J; 1981; 57 Suppl 2():19-22. PubMed ID: 7322955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of altered noradrenaline reactivity in essential hypertension by indapamide.
    Grimm M; Weidmann P; Meier A; Keusch G; Ziegler W; Glück Z; Beretta-Piccoli C
    Br Heart J; 1981 Oct; 46(4):404-9. PubMed ID: 7295437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects.
    Mroczek WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):61-7. PubMed ID: 6856486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L; Meschi T; Guerra A; Novarini A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short and long-term indapamide treatments on urinary calcium excretion in patients with calcium oxalate dihydrate urinary stone disease: a pilot study.
    Alonso D; Pieras E; Pizá P; Grases F; Prieto RM
    Scand J Urol Nephrol; 2012 Apr; 46(2):97-101. PubMed ID: 22251010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and clinical pharmacology of indapamide.
    Caruso FS; Szabadi RR; Vukovich RA
    Am Heart J; 1983 Jul; 106(1 Pt 2):212-20. PubMed ID: 6869203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and micro-albuminuria in diabetic patients taking indapamide.
    Janka HU; Weitz T; Blümner E; van Michel A; Mehnert H
    J Hypertens Suppl; 1989 Dec; 7(6):S316-7. PubMed ID: 2632730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effect of indapamide.
    Gragnoli G; Puccetti F; Nami R; Tanganelli I; Favilli R; Betti E
    Minerva Med; 1977 Mar; 68(12):749-60. PubMed ID: 846677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of idiopathic hypercalciuria with indapamide.
    Lemieux G
    CMAJ; 1986 Jul; 135(2):119-21. PubMed ID: 3719496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension.
    Ohta Y; Kamide K; Hanada H; Morimoto S; Nakahashi T; Takiuchi S; Ishimitsu T; Tsuchihashi T; Soma M; Tomohiro Katsuya T; Sugimoto K; Rakugi H; Oukura T; Higaki J; Matsuura H; Shinagawa T; Miwa Y; Sasaguri T; Igase M; Miki T; Takeda K; Higashiura K; Shimamoto K; Katabuchi R; Ueno M; Hosomi N; Kato J; Komai N; Kojima S; Sase K; Iwashima Y; Yoshihara F; Horio T; Nakamura S; Nakahama H; Miyata T; Kawano Y
    Hypertens Res; 2020 Mar; 43(3):220-226. PubMed ID: 31748705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive therapy in diabetic patients. The use of indapamide.
    Harrower AD; McFarlane G
    Am J Med; 1988 Jan; 84(1B):89-91. PubMed ID: 3277423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of indapamide: final results of a two-year Italian multicenter study in systemic hypertension.
    Leonetti G; Rappelli A; Salvetti A; Scapellato L
    Am J Cardiol; 1990 May; 65(17):67H-71H. PubMed ID: 2184655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effect of indapamide given in conjunction with captopril in severe hypertension.
    Kocijancic M; Dimkovic S
    Curr Med Res Opin; 1986; 10(5):313-8. PubMed ID: 3545687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.
    Yamada H; Mishiro Y; Kusunose K; Sata M
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.